Alimera Sciences, Inc. News Headlines

ALIM 
$5.87
*  
0.02
0.34%
Get ALIM Alerts
*Delayed - data as of Jul. 9, 2014  -  Find a broker to begin trading ALIM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Update on pSivida's Iluvien - Analyst Blog
12/19/2013 5:17:45 PM - Zacks.com

Healthcare Stocks Closing Lower; Opko Sells Sorrento Therapeutics Stake For 10-Fold Gain on 2009 Investment
12/19/2013 4:48:10 PM - MT Newswires

Sector Update: Healthcare
12/19/2013 4:46:56 PM - MT Newswires

Healthcare Stocks in Decline; Oxygen Biotherapeutics Rallies on Plans to Bring Heart Drug to Late-Stage Trial
12/19/2013 2:50:05 PM - MT Newswires

Sector Update: Healthcare
12/19/2013 2:48:07 PM - MT Newswires

PSivida: Game On
12/19/2013 11:40:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Lower Pre-Market; Vertex Sinks On Phase 3 Study of Ivacaftor
12/19/2013 9:35:02 AM - MT Newswires

Sector Update: Healthcare
12/19/2013 9:34:20 AM - MT Newswires

Final Guidance from NICE for pSivida's Iluvien - Analyst Blog
12/5/2013 6:00:01 PM - Zacks.com

Alimera Sciences Inc. is now in Oversold Territory - Tale of the Tape
11/15/2013 9:48:01 AM - Zacks.com

Alimera Down on 3rd Iluvien CRL - Analyst Blog
10/21/2013 6:07:13 PM - Zacks.com

pSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien
10/20/2013 6:06:00 PM - Seeking Alpha

pSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien
10/20/2013 5:13:46 PM - SeekingAlpha

pSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien
10/20/2013 5:13:00 PM - Seeking Alpha

pSivida: Previewing The Possible Effect On The Stock Of The October 17th PDUFA Date For Iluvien
10/7/2013 7:57:00 PM - Seeking Alpha

pSivida Corporation: Strong Takeover Target, October 17th PDUFA Date Make It A Buy
10/7/2013 4:00:00 AM - Seeking Alpha

A Closer Look At PSivida's Pipeline
9/16/2013 5:31:00 PM - Seeking Alpha

Trade the Earnings: Alimera Sciences, Inc.
8/12/2013 6:26:30 AM - MT Newswires

FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha

pSivida Starts Phase III Study - Analyst Blog
7/5/2013 5:15:01 PM - Zacks.com

Draft Guidance from NICE for pSivida's Iluvien - Analyst Blog
6/21/2013 4:31:54 PM - Zacks.com

What Iluvien May Mean To Alimera And PSivida
6/5/2013 12:30:00 PM - Seeking Alpha

SmithOnStocks Opines Week Of June 2, 2013
6/3/2013 7:00:00 AM - Seeking Alpha

Ophthalmology Innovators: Will InSite Follow Recent Successes?
5/16/2013 3:59:00 PM - Seeking Alpha

Alimera Sciences And Trius Therapeutics: 2 Big Biotechs For 2013
5/13/2013 6:57:00 AM - Seeking Alpha